SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062909
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:40
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20230930.htm   iXBRL 10-Q 3113036
2 EX-10.1 igms-ex10_1.htm EX-10.1 139507
3 EX-31.1 igms-ex31_1.htm EX-31.1 16761
4 EX-31.2 igms-ex31_2.htm EX-31.2 15271
5 EX-32.1 igms-ex32_1.htm EX-32.1 9873
6 EX-32.2 igms-ex32_2.htm EX-32.2 9853
  Complete submission text file 0000950170-23-062909.txt   9542080

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igms-20230930_cal.xml EX-101.CAL 44418
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20230930_pre.xml EX-101.PRE 341889
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20230930.xsd EX-101.SCH 56858
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igms-20230930_def.xml EX-101.DEF 216292
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20230930_lab.xml EX-101.LAB 468255
57 EXTRACTED XBRL INSTANCE DOCUMENT igms-20230930_htm.xml XML 1570685
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 231398592
SIC: 2834 Pharmaceutical Preparations